Cargando…
First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis
Endothelin (ET) receptor antagonists are potentially novel therapeutic agents in chronic kidney disease and resistant hypertension, but their use is complicated by sodium and water retention. In animal studies, this side effect arises from ET(B) receptor blockade in the renal tubule. Previous attemp...
Autores principales: | Hunter, Robert W., Moorhouse, Rebecca, Farrah, Tariq E., MacIntyre, Iain M., Asai, Takae, Gallacher, Peter J., Kerr, Debbie, Melville, Vanessa, Czopek, Alicja, Morrison, Emma E., Ivy, Jess R., Dear, James W., Bailey, Matthew A., Goddard, Jane, Webb, David J., Dhaun, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739104/ https://www.ncbi.nlm.nih.gov/pubmed/28507171 http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.08832 |
Ejemplares similares
-
Dissociation of natriuresis and diuresis by oxytocin molecular forms in rats
por: Jankowski, Marek, et al.
Publicado: (2019) -
Impaired pressure natriuresis and non‐dipping blood pressure in rats with early type 1 diabetes mellitus
por: Culshaw, Geoffrey J., et al.
Publicado: (2018) -
A novel role for myeloid endothelin-B receptors in hypertension
por: Czopek, Alicja, et al.
Publicado: (2019) -
Impairment of natriuresis and diuresis induced by intrarenal adrenoceptor mechanisms in an experimental model of cirrhosis in rats
por: Milanez, Maycon I.O., et al.
Publicado: (2019) -
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease
por: Farrah, Tariq E., et al.
Publicado: (2019)